Annual Current Assets
$7.15 M
-$4.18 M-36.87%
December 1, 2023
Summary
- As of March 2, 2025, NBY annual total current assets is $7.15 million, with the most recent change of -$4.18 million (-36.87%) on December 1, 2023.
- During the last 3 years, NBY annual current assets has fallen by -$7.09 million (-49.77%).
- NBY annual current assets is now -68.58% below its all-time high of $22.77 million, reached on December 31, 2007.
Performance
NBY Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$2.28 M
+$26.00 K+1.15%
September 1, 2024
Summary
- As of March 2, 2025, NBY quarterly total current assets is $2.28 million, with the most recent change of +$26.00 thousand (+1.15%) on September 1, 2024.
- Over the past year, NBY quarterly current assets has dropped by -$5.93 million (-72.25%).
- NBY quarterly current assets is now -89.99% below its all-time high of $22.77 million, reached on December 31, 2007.
Performance
NBY Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
NBY Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -36.9% | -72.3% |
3 y3 years | -49.8% | -79.7% |
5 y5 years | -16.9% | -79.7% |
NBY Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -45.7% | at low | -82.7% | +1.1% |
5 y | 5-year | -49.8% | at low | -85.8% | +1.1% |
alltime | all time | -68.6% | +117.1% | -90.0% | +1.1% |
NovaBay Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.28 M(+1.2%) |
Jun 2024 | - | $2.25 M(-37.3%) |
Mar 2024 | - | $3.59 M(-49.8%) |
Dec 2023 | $1.88 M(-62.9%) | $7.15 M(-12.9%) |
Sep 2023 | - | $8.21 M(-26.8%) |
Jun 2023 | - | $11.22 M(+13.4%) |
Mar 2023 | - | $9.89 M(-12.7%) |
Dec 2022 | $5.07 M(-53.1%) | $11.33 M(+6.8%) |
Sep 2022 | - | $10.61 M(+12.2%) |
Jun 2022 | - | $9.46 M(-24.2%) |
Mar 2022 | - | $12.48 M(-5.3%) |
Dec 2021 | $10.81 M(+985.1%) | $13.17 M(+14.6%) |
Sep 2021 | - | $11.50 M(-10.0%) |
Jun 2021 | - | $12.77 M(-2.8%) |
Mar 2021 | - | $13.15 M(-7.7%) |
Dec 2020 | $996.00 K(-45.8%) | $14.24 M(-11.1%) |
Sep 2020 | - | $16.01 M(+34.5%) |
Jun 2020 | - | $11.91 M(+51.2%) |
Mar 2020 | - | $7.87 M(-16.1%) |
Dec 2019 | $1.84 M(+144.2%) | $9.38 M(-24.9%) |
Sep 2019 | - | $12.50 M(+66.7%) |
Jun 2019 | - | $7.50 M(+5.4%) |
Mar 2019 | - | $7.12 M(-17.3%) |
Dec 2018 | $753.00 K(-30.5%) | $8.61 M(-9.7%) |
Sep 2018 | - | $9.53 M(-11.5%) |
Jun 2018 | - | $10.77 M(-15.8%) |
Mar 2018 | - | $12.79 M(+42.2%) |
Dec 2017 | $1.08 M(+19.1%) | $8.99 M(-9.5%) |
Sep 2017 | - | $9.94 M(-9.4%) |
Jun 2017 | - | $10.97 M(-4.9%) |
Mar 2017 | - | $11.53 M(-20.3%) |
Dec 2016 | $910.00 K(+65.5%) | $14.47 M(+0.4%) |
Sep 2016 | - | $14.42 M(+119.3%) |
Jun 2016 | - | $6.57 M(+44.1%) |
Mar 2016 | - | $4.56 M(+0.8%) |
Dec 2015 | $550.00 K | $4.53 M(-26.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2015 | - | $6.18 M(-36.0%) |
Jun 2015 | - | $9.65 M(+27.0%) |
Mar 2015 | - | $7.60 M(+9.3%) |
Dec 2014 | $585.00 K(-31.9%) | $6.95 M(-33.3%) |
Sep 2014 | - | $10.42 M(-19.1%) |
Jun 2014 | - | $12.88 M(-21.4%) |
Mar 2014 | - | $16.38 M(+10.8%) |
Dec 2013 | $859.00 K(-10.0%) | $14.79 M(+28.8%) |
Sep 2013 | - | $11.48 M(-4.2%) |
Jun 2013 | - | $11.99 M(-17.5%) |
Mar 2013 | - | $14.53 M(-20.5%) |
Dec 2012 | $954.00 K(-32.1%) | $18.28 M(+46.1%) |
Sep 2012 | - | $12.52 M(+15.0%) |
Jun 2012 | - | $10.89 M(-14.9%) |
Mar 2012 | - | $12.79 M(-12.2%) |
Dec 2011 | $1.41 M(-20.3%) | $14.56 M(-13.3%) |
Sep 2011 | - | $16.79 M(+25.1%) |
Jun 2011 | - | $13.41 M(+3.7%) |
Mar 2011 | - | $12.93 M(-6.0%) |
Dec 2010 | $1.76 M(-8.1%) | $13.75 M(+23.1%) |
Sep 2010 | - | $11.17 M(-4.6%) |
Jun 2010 | - | $11.71 M(-17.6%) |
Mar 2010 | - | $14.21 M(-9.0%) |
Dec 2009 | $1.92 M(+31.7%) | $15.61 M(+16.0%) |
Sep 2009 | - | $13.46 M(+17.5%) |
Jun 2009 | - | $11.45 M(-15.5%) |
Mar 2009 | - | $13.56 M(+8.4%) |
Dec 2008 | $1.46 M(+26.6%) | $12.51 M(-21.7%) |
Sep 2008 | - | $15.97 M(-9.4%) |
Jun 2008 | - | $17.63 M(-15.3%) |
Mar 2008 | - | $20.82 M(-8.6%) |
Dec 2007 | $1.15 M(+107.6%) | $22.77 M(+214.3%) |
Sep 2007 | - | $7.25 M(-13.7%) |
Jun 2007 | - | $8.40 M(-20.5%) |
Mar 2007 | - | $10.56 M(-6.6%) |
Dec 2006 | $554.00 K(+107.5%) | $11.31 M(+243.3%) |
Dec 2005 | $267.00 K | $3.29 M |
FAQ
- What is NovaBay Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual current assets year-on-year change?
- What is NovaBay Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly current assets year-on-year change?
What is NovaBay Pharmaceuticals annual total current assets?
The current annual current assets of NBY is $7.15 M
What is the all time high annual current assets for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual total current assets is $22.77 M
What is NovaBay Pharmaceuticals annual current assets year-on-year change?
Over the past year, NBY annual total current assets has changed by -$4.18 M (-36.87%)
What is NovaBay Pharmaceuticals quarterly total current assets?
The current quarterly current assets of NBY is $2.28 M
What is the all time high quarterly current assets for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly total current assets is $22.77 M
What is NovaBay Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, NBY quarterly total current assets has changed by -$5.93 M (-72.25%)